Cesar A. Perez, M.D.

Cesar A. Perez, M.D.

Cesar A. Perez, M.D.

Cesar A. Perez, M.D.

  • Assistant Professor of Medicine
James Graham Brown Cancer Center
529 South Jackson Street
Louisville, KY 40202

502-852-2522 - Academic Office
502-562-4370 - Patient Appointments


Clinical Expertise
Hematology; Medical Oncology

 

Board Certifications

  • American Board of Internal Medicine -
    Internal Medicine / Medical Oncology / Hematology

Education and Training

  • Medical School: University of Panama
  • Residency: Rosalind Franklin University of Medicine and Science; Cleveland Clinic Florida
  • Fellowship: University of Miami Sylvester Comprehensive Cancer Center

 

Recent Publications

    • Perez CA, Velez M, Raez LE, Santos ES. Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation. Lung Cancer. 2014 Feb 8. pii: S0169-5002(14)00064-6. doi: 10.1016/j.lungcan.2014.02.001. [Epub ahead of print] Review. PubMed PMID: 24598368.
    • Westin GF, Perez CA, Wang E, Glück S. Biologic impact and clinical implication of mTOR inhibition in metastatic breast cancer. Int J Biol Markers. 2013 Aug 29;28(3):233-241. doi: 10.5301/JBM.5000040. [Epub ahead of print] PubMed PMID: 23999849.
    • Van Driessche F, Perez CA. Hodgkin lymphoma in pregnancy: achieving the best outcome for both mother and infant. Clin Adv Hematol Oncol. 2013 Aug;11(8):537-8. PubMed PMID: 24518428.
    • Perez CA, Song H, Raez LE, Agulnik M, Grushko TA, Dekker A, Stenson K, Blair EA, Olopade OI, Seiwert TY, Vokes EE, Cohen EE. Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck. Oral Oncol. 2012 Sep;48(9):887-92. doi: 10.1016/j.oraloncology.2012.03.020. Epub 2012 Apr 17. PubMed PMID: 22513208.
    • Perez CA, Santos ES, Arango BA, Raez LE, Cohen EE. Novel molecular targeted therapies for refractory thyroid cancer. Head Neck. 2012 May;34(5):736-45. doi: 10.1002/hed.21755. Epub 2011 May 4. Review. PubMed PMID: 21544895.
    • Belalcazar A, Azaña D, Perez CA, Raez LE, Santos ES. Targeting the Met pathway in lung cancer. Expert Rev Anticancer Ther. 2012 Apr;12(4):519-28. doi: 10.1586/era.12.16. Review. PubMed PMID: 22500688.
    • Perez CA, Arango BA, Velez M, Raez LE, Santos ES. Emerging role of multikinase inhibitors for refractory thyroid cancer. Biologics. 2012;6:257-65. doi: 10.2147/BTT.S24465. Epub 2012 Aug 8. PubMed PMID: 22904617; PubMed Central PMCID: PMC3421474.
    • Perez CA, Amin J, Aguina LM, Cioffi-Lavina M, Santos ES. Primary Mediastinal Large B-Cell Lymphoma during Pregnancy. Case Rep Hematol. 2012;2012:197347. doi: 10.1155/2012/197347. Epub 2012 Oct 31. PubMed PMID: 23198190; PubMed Central PMCID: PMC3502794.
    • Velez M, Arango BA, Perez CA, Santos ES. Safety and efficacy of pemetrexed in maintenance therapy of non-small cell lung cancer. Clin Med Insights Oncol. 2012;6:117-24. doi: 10.4137/CMO.S6248. Epub 2012 Feb 20. PubMed PMID: 22412303; PubMed Central PMCID: PMC3290110.
    • Perez CA, Santos ES, Raez LE. Active immunotherapy for non-small-cell lung cancer: moving toward a reality. Expert Rev Anticancer Ther. 2011 Oct;11(10):1599-605. doi: 10.1586/era.11.155. Review. PubMed PMID: 21999133.